#CathWorks

Thiard News@F4F

@newsen.bsky.social

1 week ago

Groundbreaking Clinical Trial Shows CathWorks FFRangio Matches Traditional PCI Outcomes A recent clinical trial at CRT 2026 revealed that CathWorks FFRangio technology led to outcomes comparable to invasive PCI methods in over 4,000 patients.

Groundbreaking Clinical Trial Shows CathWorks FFRangio Matches Traditional PCI Outcomes #USA #Washington #Clinical_Trial #CathWorks #FFRangio

Thiard News@F4F

@newsen.bsky.social

1 month ago

CathWorks FFRangio's Impact on Coronary Artery Disease Assessment Confirmed by SCAI Experts The recent SCAI expert opinion highlights CathWorks FFRangio's innovative ADP approach for coronary artery disease assessment, ensuring superior patient outcomes.

CathWorks FFRangio's Impact on Coronary Artery Disease Assessment Confirmed by SCAI Experts #United_States #Newport_Beach #CathWorks #FFRangio #SCAI

Thiard News@F4F

@newsen.bsky.social

1 month ago

Medtronic's Strategic Move: Acquisition of CathWorks to Enhance Cardiovascular Solutions Medtronic plans to acquire CathWorks, enhancing its capabilities in cardiovascular healthcare through innovative technology and partnership.

Medtronic's Strategic Move: Acquisition of CathWorks to Enhance Cardiovascular Solutions #Ireland #Medtronic #Galway #CathWorks #FFRangio

Thiard News@F4F

@newsen.bsky.social

4 months ago

CathWorks Unveils Exciting Agenda for TCT 2025 Conference in San Francisco Discover the groundbreaking events lined up by CathWorks at the TCT 2025 conference, spotlighting their innovative FFRangio® System.

CathWorks Unveils Exciting Agenda for TCT 2025 Conference in San Francisco #United_States #San_Francisco #CathWorks #FFRangio #TCT_2025

Thiard News@F4F

@newsen.bsky.social

9 months ago

New Findings from the PROVISION Study Highlight Clinical Similarity of FFRangio and Traditional FFR At EuroPCR 2025, the PROVISION study revealed that FFRangio offers clinical outcomes comparable to traditional FFR, indicating a shift in treatment approaches.

New Findings from the PROVISION Study Highlight Clinical Similarity of FFRangio and Traditional FFR #Japan #CathWorks #FFRangio #Gifu #EuroPCR

Thiard News@F4F

@newsen.bsky.social

9 months ago

CathWorks Unveils Key Participation Schedule for EuroPCR 2025 Conference in Paris CathWorks announces its significant involvement and key events at EuroPCR 2025, highlighting advancements in digital health for cardiovascular care.

CathWorks Unveils Key Participation Schedule for EuroPCR 2025 Conference in Paris #USA #Newport_Beach #CathWorks #FFRangio #EuroPCR

Thiard News@F4F

@newsen.bsky.social

9 months ago

CathWorks Unveils Exciting Events for EuroPCR 2025 Conference in Paris CathWorks announces its lineup of key events for EuroPCR 2025, showcasing its innovative FFRangio technology and expert-led discussions.

CathWorks Unveils Exciting Events for EuroPCR 2025 Conference in Paris #USA #Newport_Beach #CathWorks #FFRangio #EuroPCR2025

Thiard News@F4F

@newsen.bsky.social

1 year ago

CathWorks Celebrates Completion of Enrollment for Groundbreaking ALL-RISE Trial in Cardiovascular Health CathWorks proudly announces full enrollment in the ALL-RISE trial, a pivotal study assessing its innovative FFRangio System for coronary disease diagnosis and treatment.

CathWorks Celebrates Completion of Enrollment for Groundbreaking ALL-RISE Trial in Cardiovascular Health #United_States #Clinical_Trial #Newport_Beach #CathWorks #FFRangio

Thiard News@F4F

@newsen.bsky.social

1 year ago

CathWorks Completes Enrollment for ALL-RISE Clinical Trial, Paving the Way for Advancements in Cardiac Diagnostics CathWorks has successfully completed enrollment for the ALL-RISE trial, a pivotal study aiming to enhance cardiac diagnostics through innovative methods and technology.

CathWorks Completes Enrollment for ALL-RISE Clinical Trial, Paving the Way for Advancements in Cardiac Diagnostics #United_States #Newport_Beach #CathWorks #FFRangio #cardiac_trials

Thiard News@F4F

@newsen.bsky.social

1 year ago

CathWorks Completes Enrollment in Groundbreaking ALL-RISE Trial for Coronary Artery Disease Treatment CathWorks has successfully enrolled over 1,900 patients in the ALL-RISE trial, a significant landmark study assessing coronary artery disease treatment. This trial may set a new standard of care.

CathWorks Completes Enrollment in Groundbreaking ALL-RISE Trial for Coronary Artery Disease Treatment #USA #Newport_Beach #CathWorks #FFRangio #coronary